SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-061467
Filing Date
2017-11-29
Accepted
2017-11-29 16:15:02
Documents
2
Period of Report
2017-11-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv480423_8k.htm 8-K 25761
2 EXHIBIT 2.1 tv480423_ex2-1.htm EX-2.1 26165
  Complete submission text file 0001144204-17-061467.txt   53297
Mailing Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121 (858) 909-0749
Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31326 | Film No.: 171228487
SIC: 8731 Services-Commercial Physical & Biological Research